US20190192320A1 - Prosthesis having an everting pivoting fenestration - Google Patents
Prosthesis having an everting pivoting fenestration Download PDFInfo
- Publication number
- US20190192320A1 US20190192320A1 US16/292,456 US201916292456A US2019192320A1 US 20190192320 A1 US20190192320 A1 US 20190192320A1 US 201916292456 A US201916292456 A US 201916292456A US 2019192320 A1 US2019192320 A1 US 2019192320A1
- Authority
- US
- United States
- Prior art keywords
- prosthesis
- band
- support frame
- perimeter
- fenestration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/954—Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
Abstract
The present disclosure relates to an endoluminal prosthesis, such as a stent graft that includes one or more fenestrations to accommodate endovascular disease, such as an aneurysm in cases where one or more side branches is involved. In one aspect, the prosthesis includes fenestrations that are pivotable to accommodate the dynamic geometry of the aortic branches. In another aspect, the pivotable fenestrations include a first perimeter, a band of flexible material attached and surrounding the first perimeter, a second perimeter attached to and surrounding the band of flexible material and a support frame disposed about a surface of the band of flexible material. The first perimeter, band of flexible material, and second perimeter have a geometric shape. The support frame includes a plurality of support units having curved segments. The curved segments of the support units may be concave with respect to an exterior surface of the prosthesis.
Description
- The present application is a divisional application that claims priority to U.S. Utility application Ser. No. 13/826,289 filed Mar. 14, 2013, entitled Prosthesis Having An Everting Pivoting Fenestration, which is incorporated by reference in its entirety.
- The functional vessels of human and animal bodies, such as blood vessels and ducts, occasionally weaken or even rupture. For example, the aortic wall can weaken, resulting in an aneurysm, or it may develop a tear in one of the layers of the aortic wall resulting in an aortic dissection.
- One common surgical intervention for weakened, aneurysmal or ruptured passageways or ducts involves the use of an endoluminal prosthesis to provide some or all of the functionality of the original, healthy passageway or duct and/or preserve any remaining vascular integrity by replacing a length of the existing passageway or duct wall that spans the site of failure or defect. Endoluminal prostheses may be of a unitary construction or may be comprised of multiple prosthetic modules. They also may be a single tubular device or a bifurcated branching device depending on the desired application.
- In many cases, however, the damaged or defective portion of the vasculature may include a branch vessel branching from the main vessel. For example, in the case of the abdominal aorta, there are at least three major branch vessels, including the celiac, mesenteric, and renal arteries, as well as others, leading to various other body organs. Thus, when the damaged portion of the vessel includes one or more of these branch vessels, some accommodation must be made to ensure that the prosthesis does not block or hinder blood flow through the branch vessel. In many instances, there may be insufficient healthy tissue in the aorta near the branching vessels to adequately seal a prosthesis without partially or completely blocking one or more of the branching vessels.
- The present disclosure relates to an endoluminal prosthesis, such as a stent graft, that includes one or more fenestrations to accommodate endovascular disease, such as an aneurysm, in cases where one or more side branches are involved. In one aspect, the prosthesis includes fenestrations that are pivotable to accommodate the dynamic geometry of the aortic branches. The use of pivotable fenestrations also allows the design of a family of standard stent grafts for “off-the-shelf” use to accommodate a majority of aneurysm cases involving side branches and reducing the need for customization in many cases.
- In one aspect, a prosthesis includes one or more pivotable fenestrations that accommodate the variability associated with patient anatomy, both statically and dynamically. For example, one or more pivotable fenestrations provided on a prosthesis may lie outside the surface plane of the body of the prosthesis and will allow a branch vessel stent, graft or stent-graft that has been placed in the fenestration to pivot into any orientation required to meet and seal the branch vessel device in the branch vessel.
- The pivotable fenestrations may include an inner perimeter surrounding the fenestration (the hole) in the graft, a band of material surrounding the inner perimeter and extending radially outwardly from the surface plane of the prosthesis, and an outer perimeter surrounding the band of material where the band joins the surface of the prosthesis. The band of material extending from the surface of the prosthesis is sufficiently flexible to permit the fenestration to move such that a branch stent disposed in the fenestration may be oriented upwardly, downwardly, laterally, diagonally and the like. Hence, a device of a single geometry may accommodate a variety of patient anatomies.
- In a further aspect, the inner perimeter, the band of material, and the outer perimeter may have a geometric shape and include a support frame disposed about a surface of the band of material. In one embodiment, the support frame includes a plurality of support units having curved segments interconnected by a plurality of apices; a circular reinforcement member disposed on an end of the support frame; and at least one flange positioned on an end of the support frame opposite of the reinforcement member. The curved segments may curve radially outward and away from a longitudinal axis of the prosthesis. The curved segments may have a generally concave configuration with respect to the exterior surface of the prosthesis. The support frame may also include a flange. In some embodiments, the flange may be comprised of a portion of a curved segment and at least one apex. In some embodiments, the support frame is monostable. The band of material may have a depth relative to the surface plane of the prosthesis. The prosthesis may include one stent that is positioned in an out-of-phase configuration with the remaining stents. The inner perimeter, the band, and the outer perimeter of the pivotable fenestration may be at least partially demarcated by the struts of a stent positioned on the body of the stent graft. The support frame may, in some embodiments, comprise helical support units.
- The foregoing paragraphs have been provided by way of general introduction, and are not intended to limit the scope of the following claims. The presently preferred embodiments, together with further advantages, will be best understood by reference to the following detailed description taken in conjunction with the accompanying drawings.
-
FIG. 1 shows an embodiment of a fenestrated prosthesis having everting pivotable fenestrations. -
FIG. 2 shows an enlarged view of a pivotable fenestration shown inFIG. 1 . -
FIG. 3 shows a perspective view of a support frame for a fenestrated prosthesis having everting pivotable fenestrations shown inFIG. 1 . -
FIG. 4 is a partial and internal view of the prosthesis as shown inFIG. 1 . -
FIG. 5a shows a view from within the lumen of an embodiment of a fenestrated prosthesis having an embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 5b shows a view from the exterior of an embodiment of a fenestrated prosthesis having an embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 5c shows a side cross-sectional view of an embodiment of a fenestrated prosthesis having an embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 6a shows a view from within the lumen of an embodiment of a fenestrated prosthesis having an alternative embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 6b shows a view from the exterior of an embodiment of a fenestrated prosthesis having an alternative embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 6c shows a side cross-sectional view of an embodiment of a fenestrated prosthesis having an alternative embodiment of a retention assembly for restraining everting pivotable fenestrations of a fenestrated device. -
FIG. 7 shows an embodiment of a delivery device used with a retention system for deployment of a fenestrated prosthesis having everting pivotable fenestrations. - The present disclosure relates to an endoluminal prosthesis, such as a stent graft that includes one or more fenestrations to accommodate endovascular disease, such as an aneurysm in cases where one or more side branches are involved, and a side branch prosthesis is deployed within the fenestration to permit fluid flow from the endoluminal prosthesis into the branch vessel. The prosthesis includes fenestrations that pivot as needed to accommodate the dynamic geometry of the aortic branches. In various aspects shown and described in more detail below, for example, one or more pivotable fenestrations provided on a prosthesis lie outside the surface plane of the body of the prosthesis and will allow a branch vessel stent, graft or stent-graft that has been placed in the fenestration to pivot into a variety of orientations required to meet and seal the branch vessel device in the branch vessel. The orientation of the fenestrations may dynamically change over time as needed by changing anatomy.
- Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs.
- The term “distal” means a location or direction that is, or a portion of a device that when implanted is further downstream in the direction of or with respect to blood flow.
- The term “proximal” means a location or direction that is, or a portion of a device that when implanted is further upstream in the direction of or with respect to blood flow.
- The term “fenestration” means an opening provided through a surface of a prosthesis from the interior of the prosthesis to the exterior of the prosthesis and may have a variety of geometries, including circular, semi-circular, oval, oblong, as well as other geometries.
- The term “biocompatible” refers to a material that is substantially non-toxic in the in vivo environment of its intended use, and that is not substantially rejected by the patient's physiological system (i.e., is non-antigenic). Examples of biocompatible materials from which textile graft material can be formed include, without limitation, polyesters, such as polyethylene terephthalate, fluorinated polymers, such as polytetrafluoroethylene (PTFE) and fibers of expanded PTFE, and polyurethanes. In addition, materials that are not inherently biocompatible may be subjected to surface modifications in order to render the materials biocompatible. Examples of surface modifications include graft polymerization of biocompatible polymers on the materials surface, coating of the surface with a cross-linked biocompatible polymer, chemical modification with biocompatible functional groups, and immobilization of a compatibilizing agent such as heparin or other biocompatible substances. Thus, any fibrous material having sufficient strength to survive in the in vivo environment may be used to form a textile graft, provided the final textile is biocompatible. Fibers suitable for making textile grafts include polyethylene, polypropylene, polyaramids, polyacrylonitrile, nylon, and cellulose, in addition to the polyesters, fluorinated polymers, and polyurethanes as listed above. Furthermore, bioremodelable materials may also be used singly or in combination with the aforementioned polymer materials. The textile may be made of one or more polymers that do not require treatment or modification to be biocompatible. The graft may be constructed from woven multifilament polyester, for example and without limitation, Dacron™, produced by DuPONT. Dacron™ is known to be sufficiently biologically inert, non-biodegradable, and durable to permit safe insertion inside the human body.
- The term “prosthesis” means any device for insertion or implantation into or replacement for a body part or function of that body part. It may also mean a device that enhances or adds functionality to a physiological system. The term prosthesis may include, for example and without limitation, a stent, stent-graft, filter, valve, balloon, embolization coil, and the like.
- The term “tubular” refers to the general shape of an endoluminal device which allows the module to carry fluid along a distance or fit within a tubular structure such as an artery. Tubular prosthetic devices include single, branched, and bifurcated devices. Tubular may refer to any shape including, but not limited to, tapered, cylindrical, curvilinear, or any combination thereof. A tubular device may have a cross-sectional shape that is, circular, substantially circular or the like. However, it should be understood that the cross-sectional shape is not limited thereto, and other shapes, such as, for example, hexagonal, pentagonal, octagonal, or the like are contemplated. The term “endoluminal” refers to or describes objects that can be placed inside a lumen or a body passageway in a human or animal body. A lumen or a body passageway can be an existing lumen or a lumen created by surgical intervention. As used in this specification, the terms “lumen” or “body passageway” are intended to have a broad meaning and encompass any duct (e.g., natural or iatrogenic) within the human body and can include a member selected from the group comprising: blood vessels, respiratory ducts, gastrointestinal ducts, and the like. “Endoluminal device” or “endoluminal prosthesis” thus describes devices that can be placed inside one of these lumens.
- The term “graft” or “graft material” describes an object, device, or structure that is joined to or that is capable of being joined to or implanted in or against a body part to enhance, repair, or replace a portion or a function of that body part. A graft by itself or with the addition of other elements, such as structural components, may comprise an endoluminal prosthesis. The graft may be comprised of a single material, a blend of materials, a weave, a laminate, or a composite of two or more materials. The graft may be constructed from natural or organic materials, for example and without limitation, a biological scaffold or bioremodelable material, such as small intestine submucosa (“SIS”), which is commercially available by Cook Biotech, West Lafayette, Ind. The graft may also be constructed from a synthetic material, for example and without limitation, a polymer. The graft may be formed from a single layer or multiple layers of material. In embodiments employing a plurality of layers of material, the layers may remain separate, or may be attached to each other through a secondary process such as sintering, curing, adhesives, and sutures or the like.
- The term “stent” means any device or structure that adds rigidity, expansion force or support to a prosthesis. A stent is used to obtain and maintain the patency of the body passageway while maintaining the integrity of the passageway. Also, the stent may be used to form a seal. The stent may be located on the exterior of the device, the interior of the device, or both. A stent may be self-expanding, balloon-expandable or may have characteristics of both. A variety of other stent configurations are also contemplated by the use of the term “stent.” The stents may be comprised of a metallic material selected from stainless steel, silver, platinum, palladium, gold, titanium, tantalum, iridium, tungsten, cobalt, chromium, cobalt-chromium alloy 1058, cobalt-based 35N alloy, nickel-based alloy 625, a molybdenum alloy, a molybdenum alloy including about 0.4% to about 0.8% of lanthanum oxide (Li2O3), and a nickel-titanium alloy, such as Nitinol, or other suitable materials as known in the art. The stents may be made of a wire, or may be laser or cannula cut, or manufactured by other known methods.
- The term “branch vessel” refers to a vessel that branches off from a main vessel. Examples are the celiac and renal arteries which are branch vessels to the aorta (i.e., the main vessel in this context). As another example, the hypogastric artery is a branch vessel to the common iliac, which is a main vessel in this context. Thus, it should be seen that “branch vessel” and “main vessel” are relative terms.
- “Longitudinally” refers to a direction, position or length substantially parallel with a longitudinal axis of a reference.
- “Circumferentially” refers to a direction, position, or length that encircles a longitudinal axis of reference. The term “circumferential” is not restricted to a full 360° circumferential turn or to a constant radius.
- The terms “patient,” “subject,” and “recipient” as used in this application refer to any animal, especially humans.
- The figures show a
fenestrated prosthesis 10, here a stent graft, having a tubular body and comprising a biocompatible material, having one ormore fenestrations 12 pivotable in a direction away from an axis perpendicular to a longitudinal axis of the prosthesis. For example, thefenestrations 12 may be pivotable in any direction away from an axis perpendicular to a longitudinal axis of theprosthesis 10. The pivotable fenestrations 12 include a first,inner perimeter 26 surrounding thefenestration 12 having a diameter, aband 28 of flexible material attached to and surrounding thefirst perimeter 26, and a second,outer perimeter 30 attached to and surrounding theband 28 of flexible material. Theband 28 of material has a first diameter that is substantially the same as the diameter of thefirst perimeter 26, and a second diameter substantially the same as thesecond perimeter 30. The diameter of the band of material decreases in a direction away from the surface 20 of thegraft 14 from the second perimeter to the first perimeter. Theband 28 of flexible material includes asupport frame 48 having a plurality of support units disposed about a surface of theband 28. In a deployed position, the pivotable fenestrations 12 have an everted configuration with respect to a surface of theprosthesis 10 and have a diameter extending from a side wall of the graft forming a geometric shape. Thefenestration 12 may be disposed at the apex of the geometric shape. - In some aspects, the
prosthesis 10 is intended for placement in the abdominal aorta and to accommodate vessels that branch from the aorta, for example, the renal arteries, and into which a branch vessel prosthesis may be placed. However, theprosthesis 10 is not limited for use in the abdominal aorta but may be used in other vessels of the body from which other vessels branch, such as the ascending thoracic aorta, the descending thoracic aorta, as well as other body vessels. -
FIG. 1 shows an embodiment of aprosthesis 10 that is a stent graft. Theprosthesis 10 includesgraft material 14 associated with one or more stents 16. Theprosthesis 10 has aproximal end 22, adistal end 24, and alumen 18 extending through theprosthesis 10 to permit passage of blood flow from theproximal end 22 to thedistal end 24. The stents 16 may be placed on the external surface 20 and/orinternal surface 21 of thegraft material 14. In one particular embodiment, theprosthesis 10, such as that shown inFIG. 1 , hasexternal body stents internal stent 16 f. Additionally, or alternatively, depending on the location of the place of theprosthesis 10 or a particular need, a sealingstent 45 may be placed at either or both the proximal and distal ends 22, 24 of theprosthesis 10. Theprosthesis 10 also may include an attachment mechanism, for example, anattachment stent 42, at either or both ends of theprosthesis 10, to further secure theprosthesis 10 within the body vessel and prevent migration of theprosthesis 10. Theattachment stent 42 includesbarbs 43 that may assist with securing theprosthesis 10 within the target vessel. - The
prosthesis 10 has several openings or fenestrations that extend from theinternal surface 21 to the external surface 20 of thegraft material 14. Theprosthesis 10 ofFIG. 1 has twopivotable fenestrations 12, at least onenon-pivotable fenestration 38, and ascallop 40. Here, thescallop 40 is placed at the proximal end of theprosthesis 10. As shown in greater detail inFIG. 2 , thepivotable fenestration 12 has aninner perimeter 26 surrounding thefenestration 12, aband 28 surrounding theinner perimeter 26, and anouter perimeter 30 surrounding theband 28. Theouter perimeter 30 diameter is greater than theband 28 diameter and theinner perimeter diameter 26. Theinner perimeter 26, theband 28 and theouter perimeter 30 would be substantially concentric with one another if they were in the same plane, for example the surface plane of the graft. Theinner perimeter 26, theband 28 and theouter perimeter 30 may form a geometric shape, resembling, for instance, a frustoconical cone extending from the surface of thegraft material 14. Thefenestration 12 is provided at the peak or top of the geometric shape. In other embodiments, theband 28 may comprise a tapered, flexible tube extending from theouter perimeter 30 and theinner diameter 26. In this embodiment, the pivotable fenestrations 12 have a generally circular configuration. In alternative embodiments, the pivotable fenestrations 12 may have other suitable configurations, including, but not limited to, oblong, oval, rectangular, or triangular. Asupport frame 48 having a plurality ofsupport units 50 surrounds thefenestration 12 and is positioned on a surface of theband 28. In the embodiment shown inFIGS. 1 and 2 , the frame is positioned on the outer surface of theband 28. In other embodiments, the frame may be positioned on an inner surface of theband 28. - As shown by
FIGS. 1 and 2 , thepivotable fenestration 12 has an everting configuration with respect to the surface of theprosthesis 10. As used throughout this specification, the term “everting” means extending or protruding radially outward from a surface of thegraft material 14. The term “inverting” means extending or protruding radially inward from a surface of the graft material. Theouter perimeter 30 lies substantially flush (in the same plane) of thegraft material 14, and theband 28 and theouter perimeter 30 form a geometric shape, such as a dome, or frustoconical cone extending outward from the surface of theprosthesis 10. As will be discussed below, thesupport units 50 of thesupport frame 48 help to maintain thepivotable fenestration 12 in the everting configuration when theprosthesis 10 is deployed in a patient and prevent thepivotable fenestration 12 from inverting. The pivotable fenestrations 12 are positioned to align with, for example, the renal arteries of a patient. In other aspects, the one or morepivotable fenestrations 12 may be positioned to align with other branch arteries throughout a diseased vasculature. Additional fenestrations and scallops as disclosed here may also be included. As shown in these Figures and throughout the Figures,imageable markers 35, which may be viewed during and after placement of theprosthesis 10 may be placed at various locations on theprosthesis 10 to identify certain aspects of the prosthesis and their location during the implantation procedure and facilitate correct placement of thefenestrations scallop 40, the ends of the prosthesis and the like. - In some embodiments, the
outer perimeter 30 surrounding theband 28 may be attached to thegraft material 14 by a suitable attachment method including suturing circumferentially about an aperture disposed throughgraft material 14. In alternative embodiments,inner perimeter 26,band 28, and theouter perimeter 30 may be integral with and formed from thegraft material 14 of theprosthesis 10 by creating a protrusion, as described in co-pending U.S. patent application Ser. No. 12/548,120, herein incorporated by reference. Theband 28 may be comprised of the same or different biocompatible material as thegraft material 14. For example, the biocompatible material of theband 28 may have greater pliability than the first biocompatible graft material used for the tubular graft body. Theband 28 is sufficiently flexible to permit thefenestration 12 to move such that a branch stent disposed in thefenestration 12 may be oriented upwardly, downwardly, laterally, diagonally and the like. In some embodiments, the band has up to about 180 degrees of freedom of movement relative to the surface plane of theprosthesis 10. In other embodiments, the band may have greater than 180 degrees of freedom of movement or less than 180 degrees of freedom of movement. Accordingly, thepivotable fenestration 12 allows theprosthesis 10 to be used with a variety of patients, due to its ability to adapt to the variance in the positioning of the diseased branch vessels. For example, if a body branch vessel is or becomes offset longitudinally or axially from a pivotingfenestration 12, the pivotingfenestration 12 may pivot the branch vessel prosthesis in the necessary direction and to the necessary degree to maintain the branch vessel prosthesis in place in the branch vessel. - The
band 28 may be tapered such that the diameter decreases throughout its depth. The depth of theband 28 may range from 3 to 10 mm, and preferably is about 6 mm. Theinner perimeter 26 has a diameter that is smaller than the diameter of theouter perimeter 30. The diameter of theinner perimeter 26 may be determined based on the average size of the targeted branch vessel. In this aspect, theprosthesis 10 may be used to repair a diseased renal artery. Accordingly, the average diameter of theinner perimeter 26 may be based on the average of the diameter of the openings to the renal arteries, or about 6 mm. The diameter of theouter perimeter 30 may be determined based on the desired amount of movement and the desired patency of theprosthesis 10. The diameters of theinner perimeter 26 and theouter perimeter 30, combined with depth of theband 28, provide the requisite amount of surface area for thepivotable fenestration 12 to pivot during deployment of a secondary branch prosthesis into thefenestration 12 based on dynamic changes to the anatomy. Reinforcement members may be attached to thegraft 14 surrounding the outer perimeter of thepivotable fenestrations 12. In addition, reinforcement members may be provided about the perimeter of thenon-pivoting fenestration 38, and the perimeter of thescallop 40, respectively. In one preferred aspect, the reinforcement members comprise a wire that is sutured about thefenestration scallop 40, to reinforce the fenestration or scallop. The reinforcement members may be made of any suitable material. One preferred material is a superelastic or shape memory material, such as Nitinol. In another preferred embodiment, the reinforcement members may be made of radiopaque or other imageable material. In another embodiment the reinforcement members may be a wire that is looped about itself into a ring with unattached ends such that the ring may be expanded or contracted in diameter, such as described in co-pending U.S. patent application Ser. No. 10/962,632, herein incorporated by reference. -
FIG. 3 shows an embodiment of thesupport frame 48. In a preferred aspect, thesupport frame 48 is a continuous wire formed into a plurality ofsupport units 50 comprisingcurved segments 54 having a generally concave configuration with respect to the exterior surface 20 of theprosthesis 10 joined byapices reinforcement member 44. Thereinforcement member 44 is configured to be positioned about theinner perimeter 26 of thepivotable fenestrations 12. As shown in this embodiment, thesupport frame 48 has threesupport units 50. Apices 56 a are positioned adjacent to thereinforcement member 44. The ends of the concave,curved segments 54 andapices 56 b form aflange 58 positioned on an end of thesupport frame 48 opposite of thereinforcement member 44. Theflange 58 may abut or connect to the reinforcingmember 44 positioned about theouter perimeter 30 of thepivotable fenestration 12. Theflange 58 is configured to lie generally against a surface of theband 28 and help facilitate attachment of theframe 48 to theband 28. The concave,curved segments 54 of thesupport members 50 generally curve radially outward and away from a surface of theprosthesis 10. As such, thesupport units 50 are configured to extend radially outward from the surface of theprosthesis 10 when positioned on theband 28 of thepivotable fenestration 12. Thesupport frame 48 is generally monostable, which means that the frame will always return to its expanded, resting configuration upon removal of any compression or restraint, which prevents thesupport frame 48 from inverting. While not being held to any theory, it is believed that the concave,curved segments 54 of thesupport units 50 of thesupport frame 48 help prevent any inversion of the frame. As such, thesupport frame 48 helps bias thepivotable fenestration 12 into an everting configuration with respect to a surface of theprosthesis 10 and prevents thepivotable fenestration 12 from protruding into the lumen of theprosthesis 10. In addition, thepivotable fenestration 12 having an everting configuration provides flexibility to ensure compatibility with an array of patient vessel locations. While thesupport frame 48 of this embodiment is comprised of a single, continuous wire, alternative embodiments of thesupport frame 48 may comprise a plurality of wire segments joined together to form thesupport units 50 and desired configuration of thesupport frame 48. In addition, alternative embodiments of thesupport frame 48 may comprise a continuous wire formed into one or more support units having a generally coiled helical configuration. - Referring back to
FIG. 1 , stents 16 may be configured in the form of one or more “Z-stents”, each of which may comprise a series of substantiallystraight segments 32 interconnected by a series ofbent segments 36. The bent segments may comprise acute bends or apices. The stents are arranged in a zigzag configuration in which thestraight segments outer perimeter 30 of one or more of thefenestrations 12 may lie betweenadjacent struts - Stent amplitude, spacing and stagger are preferably optimized for each prosthesis design. In some aspects, the apices or bends 36 of the
struts FIG. 1 , thestents apices 36 of each row are in circumferential alignment or “in phase”, with the apices of longitudinally adjacent rows. In addition,stent 16 e is also positioned in phase withstents Stent 16 d is positioned “out of phase” by about 180 degrees with longitudinallyadjacent row 16 c, such that circumferentially about the surface of the graft, every other apex of thestent 16 c matches with every other apex ofstent row 16 d. In other embodiments, thestent 16 d may be positioned in phase with longitudinallyadjacent row 16 c, or thestent 16 d may be out of phase withstent 16 c by an amount less than 180 degrees. Furthermore,internal stent 16 f is positioned out of phase by about 180 degrees with longitudinallyadjacent row 16 a, such that circumferentially about the surface of the graft, every other apex of thestent 16 a matches with every other apex ofstent row 16 e. In other embodiments, thestent 16 f may be positioned in phase with longitudinallyadjacent row 16 a, or theinternal stent 16 f may be out of phase withstent 16 a by an amount less than 180 degrees. In an exemplary embodiment, theinner perimeter 26, theband 28, and theouter perimeter 30 of the pivotingfenestration 12 are demarcated by a pair of longitudinally adjacent struts ofinternal stent 16 f andstent 16 a, respectively. In this embodiment, the area of theprosthesis 10 located between theinternal stent 16 f, which is out of phase, and thestent 16 a provides additional space for the movement of theband 28 of the pivotingfenestration 12, which allows for increased flexibility for the pivotingfenestration 12. -
FIG. 4 , which is a partial internal view of theprosthesis 10 ofFIG. 1 , shows a view of theprosthesis 10 looking into thelumen 18 of theprosthesis 10 from theproximal end 22. As shown,pivotable fenestrations 12 are in fluid communication with thelumen 18. Theouter perimeter 30 lies substantially flush (in the same plane) of thegraft material 14, and theband 28 and theouter perimeter 30 form a geometric, frustoconical cone shape extending outward from thelumen 18 of theprosthesis 10. In this embodiment, the pivotable fenestrations 12 are not disposed within thelumen 18 of theprosthesis 10 and fail to protrude within the lumen of the prosthesis. Theprosthesis 10 has aclear lumen 18 once theprosthesis 10 is deployed, and minimizes the possibility of blood flow through thelumen 18 being interrupted by thepivotable fenestration 12. Thepivotable fenestration 12 having an everting configuration also allows for additional room for the placement of medical devices through the fenestration to minimize the disruption to blood flow. For example, when a covered stent is placed within thepivotable fenestration 12, the lumen extension of the covered stent has additional room to minimize disruption to blood flow. -
FIGS. 5a-5c show an embodiment of aretention assembly 70 for thepivotable fenestration 12 of theprosthesis 10. Theretention system 70 includestrigger wires FIG. 5a andFIG. 5b show views from the interior and the exterior of theprosthesis 10, respectively. As showntrigger wires prosthesis 10. Thetrigger wires prosthesis 10. Thetrigger wires band 28 of pivotingfenestration 12. In order to facilitate engagement of thetrigger wires band 28. In particular,trigger wire 72 exits the lumen of theprosthesis 10 throughaperture 76 a and re-enters into the lumen throughaperture 76 b.Trigger wire 72 also exits the lumen of theprosthesis 10 throughaperture 76 c and re-enters into the lumen throughaperture 76 d. Similarly,trigger wire 74 exits the lumen of theprosthesis 10 throughaperture 76 e and re-enters into the lumen throughaperture 76 f.Trigger wire 74 also exits the lumen of theprosthesis 10 throughaperture 76 g and re-enters into the lumen throughaperture 76 h. Thetrigger wires segments 78 on an interior surface and an exterior surface of theband 28. As shown inFIG. 5a , thetrigger wires segment 78 on the interior surface of theband 28. As shown inFIG. 5b , thetrigger wires segments 78 on the exterior surface of theband 28. In addition, thesegments 78 on the exterior surface of theband 28 are positioned such that they avoid coming into contact with thesupport frame 48 of thepivotable fenestration 12. As shown, thetrigger wires graft material 14 surrounding theband 28. When the pivotable fenestrations 12 are restrained by thetrigger wires prosthesis 10, as shown inFIG. 5c . Thetrigger wires prosthesis 10. Upon removal of thetrigger wires fenestration 12 is deployed within the targeted vessel and thesupport frame 48 expands and thepivotable fenestration 12 is positioned in the everting configuration. -
FIGS. 6a-6c show an alternative embodiment of aretention assembly 80 for thepivotable fenestration 12 of theprosthesis 10.FIG. 6a andFIG. 6b show views from the interior and the exterior of theprosthesis 10, respectively. Theretention system 80 includestrigger wires trigger wires prosthesis 10. Thetrigger wires prosthesis 10. Thetrigger wires band 28 of pivotingfenestration 12. In order to facilitate engagement of thetrigger wires band 28 and thegraft material 14 surrounding theband 28. In particular,trigger wire 82 exits the lumen of theprosthesis 10 throughaperture 86 a and re-enters into the lumen throughaperture 86 b.Trigger wire 82 also exits the lumen of theprosthesis 10 throughaperture 86 c and re-enters into the lumen throughaperture 86 d.Trigger wire 82 also exits the lumen of theprosthesis 10 throughaperture 86 c and re-enters into the lumen throughaperture 86 d; exits the lumen of theprosthesis 10 through aperture 86 e and re-enters into the lumen through aperture 86 f; and exits the lumen of theprosthesis 10 throughaperture 86 g and re-enters into the lumen throughaperture 86 h. Similarly,trigger wire 84 exits the lumen of theprosthesis 10 throughaperture 86 i and re-enters into the lumen throughaperture 86 j.Trigger wire 84 also exits the lumen of theprosthesis 10 throughaperture 86 k and re-enters into the lumen through aperture 86 l; exits the lumen of theprosthesis 10 throughaperture 86 m and re-enters into the lumen throughaperture 86 n; and exits the lumen of theprosthesis 10 through aperture 86 o and re-enters into the lumen throughaperture 86 p. Thetrigger wires segments 88 on an interior surface and an exterior surface of theband 28. As shown inFIG. 6a , thetrigger wires segment 88 on the interior surface of theband 28. As shown inFIG. 6b , thetrigger wires segments 78 on the exterior surface of theband 28. In addition, thesegments 88 on the exterior surface of theband 28 are positioned such that they avoid coming into contact with thesupport frame 48 of thepivotable fenestration 12. When the pivotable fenestrations 12 are restrained by thetrigger wires prosthesis 10, as shown inFIG. 6c . Thetrigger wires prosthesis 10. Upon removal of thetrigger wires fenestration 12 is deployed within the targeted vessel and thesupport frame 48 expands and thepivotable fenestration 12 is positioned in the everting configuration. - The restrained configuration of the
pivotable fenestration 12 allows abluminal clearance between the device and a patient's branch vessel to ease cannulation. While this embodiment shows two trigger wires, other embodiments may comprise fewer trigger wires or more trigger wires to constrain thepivotable fenestrations 12. For example, one embodiment may use one trigger wire to constrain thepivotable fenestrations 12, which may reduce the width of theprosthesis 10 and provide additional space to cannulate the branch vessels. In addition, in other embodiments, the trigger wires may restrain the pivotable fenestrations 12 such that they lie in a plane that is within the lumen of theprosthesis 10 prior to deployment of the vessel. In these embodiments, the trigger wires may be slightly biased inward toward a longitudinal axis of theprosthesis 10, in order to allow for support and space for cannulation of a branch vessel. - The
retention systems FIG. 7 , thedelivery system 100 for deploying anendoluminal prosthesis 10 in a vessel of a patient includes anexternal manipulation section 101, a distal positioning mechanism orattachment region 103, and a proximal positioning mechanism orattachment region 105. Theexternal manipulation section 101, which is acted upon by a user to manipulate theintroducer 100, remains outside of the patient throughout the procedure. The proximal attachment region includes aretention device 102. Theretention device 102 has at its proximal end a long taperedflexible extension 104, or dilator. A thinwalled tube 112 generally made of metal is fastened to theextension 104. The thinwalled tube 112 is flexible so that the introducer can advance within a relatively tortuous vessel, such as the femoral artery. The thinwalled tube 112 also allows manipulation longitudinally and rotationally of theproximal attachment region 105. The thinwalled tube 112 extends throughout theintroducer 100 to themanipulation section 101, terminating at a connection means 111. The connection means 111 is adapted to accept a syringe to facilitate the introduction of reagents into themetal tube 112. Atube 114 is coaxial with and radially outside the thinwalled tube 112. Thetube 114 is “thick walled”, which is to say the thickness of the wall oftube 114 is several times that of the thinwalled tube 112. Asheath 110 is coaxial with and radially outside the thickwalled tube 112. - The
external manipulation section 101 has abody 120 that is mounted onto the thick walledplastic tube 114, which passes through thebody 120. Thepin vice 118 has ascrew cap 116. When screwed in, vice jaws (not shown) clamp against and engage the thinwalled tube 112, and the thinwalled tube 112 can only move with thebody 120, and hence can only move with the thickwalled tube 114. A proximalwire release mechanism 122 and a distalwire release mechanism 124 are mounted for slideable movement on thebody 120. Apin vice 118 is mounted onto the distal end of thebody 120. The positioning of the proximal and distalwire release mechanisms wire release mechanism 122 must be moved before the distalwire release mechanism 124 can be moved. Theretention systems - In use, the operator deploys the
delivery device 100 over a guide wire and into the patient through an artery, such as the femoral artery, via an incision and the introducer is extended up into the aortic bifurcation and positioned such that thedilator 104 is proximal of the renal arteries. Thesheath 110 is withdrawn such that theprosthesis 10 is exposed. The operator may then position theprosthesis 10 within the vessel such that the pivotable fenestrations 12 are positioned in the vicinity of the branch vessel. Once theprosthesis 10 and the pivotable fenestrations 12 are in the proper position, the operator may cannulate the branch vessels. The pivotable fenestrations remain in the restrained position by the retention mechanism, which allows for adequate space for cannulation. The operator may introduce additional endoluminal prostheses, such as an indwelling catheter for deploying a branch stent into an internal artery, as described, for example, in U.S. Pat. No. 6,524,335, herein incorporated by reference. Following cannulation, the operator may release and remove the trigger wires of theretention system support frame 48 of thepivotable fenestration 12 to expand, where thepivotable fenestration 12 has an everted configuration. In this position, the operator may introduce a branch stent into the branch vessel through thepivotable fenestration 12. - Throughout this specification various indications have been given as to preferred and alternative examples and aspects of the invention. However, the foregoing detailed description is to be regarded as illustrative rather than limiting and the invention is not limited to any one of the provided aspects. It should be understood that it is the appended claims, including all equivalents, that are intended to define the spirit and scope of this invention.
Claims (9)
1-12. (canceled)
13. A support frame for an endoluminal device having a pivoting fenestration, comprising
one or more support units having curved segments; and
a circular reinforcement member disposed on an end of the support frame;
wherein the curved segments curve radially outward.
14. The support frame of claim 13 , where the support frame comprises at least three support units.
15. The support frame of claim 13 , wherein the curved segments have a concave configuration.
16. The support frame of claim 13 , where the support units, the reinforcement member, and the flange of the support frame are comprised of a single continuous wire.
17. The support frame of claim 13 , where the curved segments of the one or more support units are interconnected by a plurality of apices.
18. The support frame of claim 17 , further comprising a flange comprised of at least a portion of a curved segment and at least one apex.
19. The support frame of claim 13 , wherein the one or more support units comprises a helical coiled configuration.
20. A delivery system for an endoluminal device, comprising
an introducer, the introducer having a distal end intended to remain outside a patient in use and a proximal end,
an endoluminal prosthesis, comprising
a graft having a tubular body and a surface comprising a first biocompatible material;
one or more stents attached about the surface of the graft;
at least one fenestration disposed through a sidewall of the graft, each fenestration having a diameter;
a first perimeter having a first diameter and surrounding the fenestration;
the first perimeter having a band of flexible material attached to and surrounding the perimeter, the band of flexible material having a depth relative to a surface plane of the tubular body; and
the band of flexible material having a second perimeter surrounding the band of flexible material; and
a support frame disposed about the surface of the band of flexible material, the support frame comprising one or more support units having curved segments; and
a retention system comprising at least one trigger wire to engage and retain the first perimeter, the band of flexible material, and the second perimeter in a restrained positioned.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/292,456 US20190192320A1 (en) | 2013-03-14 | 2019-03-05 | Prosthesis having an everting pivoting fenestration |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/826,289 US10265202B2 (en) | 2013-03-14 | 2013-03-14 | Prosthesis having an everting pivoting fenestration |
US16/292,456 US20190192320A1 (en) | 2013-03-14 | 2019-03-05 | Prosthesis having an everting pivoting fenestration |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/826,289 Division US10265202B2 (en) | 2013-03-14 | 2013-03-14 | Prosthesis having an everting pivoting fenestration |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190192320A1 true US20190192320A1 (en) | 2019-06-27 |
Family
ID=50236117
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/826,289 Active 2033-07-09 US10265202B2 (en) | 2013-03-14 | 2013-03-14 | Prosthesis having an everting pivoting fenestration |
US16/292,456 Abandoned US20190192320A1 (en) | 2013-03-14 | 2019-03-05 | Prosthesis having an everting pivoting fenestration |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/826,289 Active 2033-07-09 US10265202B2 (en) | 2013-03-14 | 2013-03-14 | Prosthesis having an everting pivoting fenestration |
Country Status (2)
Country | Link |
---|---|
US (2) | US10265202B2 (en) |
EP (1) | EP2777607B8 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190247051A1 (en) * | 2018-02-15 | 2019-08-15 | Fareed Siddiqui | Active textile endograft |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2564811B1 (en) * | 2011-08-31 | 2021-03-10 | The Cleveland Clinic Foundation | Delivery system for an endoluminal device |
US9811613B2 (en) | 2012-05-01 | 2017-11-07 | University Of Washington Through Its Center For Commercialization | Fenestration template for endovascular repair of aortic aneurysms |
US20160324670A1 (en) * | 2015-05-08 | 2016-11-10 | Dean Jared Yamaguchi | Branched Stent Grafts And Stent Graft Delivery System And Methods |
ITUA20163080A1 (en) * | 2016-05-02 | 2017-11-02 | Kardia S R L | DEVICE FOR THE TREATMENT OF PREFERABLY ANEURISMS OF THE AORTIC TYPE |
EP3468505B1 (en) * | 2016-06-13 | 2021-02-24 | Aortica Corporation | Systems and devices for marking and/or reinforcing fenestrations in prosthetic implants |
US20180021155A1 (en) | 2016-07-21 | 2018-01-25 | Cook Medical Technologies Llc | Tapered body aaa graft |
EP3493766B1 (en) | 2016-08-02 | 2024-03-06 | Bolton Medical, Inc. | Assembly for coupling a prosthetic implant to a fenestrated body |
WO2018156847A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Delivery system and method to radially constrict a stent graft |
WO2018156848A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
CN111148484B (en) | 2017-09-25 | 2022-12-30 | 波尔顿医疗公司 | Systems, devices, and methods for coupling a prosthetic implant to an open window |
CN109717986B (en) * | 2017-10-31 | 2021-07-02 | 上海微创心脉医疗科技股份有限公司 | Branch type tectorial membrane support and branch type tectorial membrane support system |
WO2019101077A1 (en) * | 2017-11-24 | 2019-05-31 | 杭州唯强医疗科技有限公司 | Shunt catheter for enhancing stability, and catheter |
CN109833116A (en) | 2017-11-24 | 2019-06-04 | 杭州唯强医疗科技有限公司 | Enhance the vascular shunt frame and intravascular stent of stability |
CN109833115A (en) | 2017-11-24 | 2019-06-04 | 杭州唯强医疗科技有限公司 | Multi-cavity overlay film frame |
CN108652787B (en) * | 2018-05-06 | 2020-05-22 | 王潇 | Covered stent for abdominal aortic aneurysm repair and using method thereof |
US11389286B2 (en) | 2018-12-05 | 2022-07-19 | Boston Scientific Scimed, Inc. | Esophageal atresia bridge device |
US11364030B2 (en) | 2019-02-15 | 2022-06-21 | Boston Scientific Scimed, Inc. | Medical device for treating esophageal atresia |
WO2020191203A1 (en) | 2019-03-20 | 2020-09-24 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
WO2022076686A1 (en) | 2020-10-07 | 2022-04-14 | Canary Medical Switzerland Ag | Providing medical devices with sensing functionality |
US11517456B2 (en) * | 2020-10-08 | 2022-12-06 | Medtronic Vascular, Inc. | Branched stent graft |
CN117224296B (en) * | 2023-11-14 | 2024-02-13 | 浙江归创医疗科技有限公司 | Window opening bracket |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1597525A (en) | 1924-01-11 | 1926-08-24 | Arthur H Knake | Washer |
US5366473A (en) | 1992-08-18 | 1994-11-22 | Ultrasonic Sensing And Monitoring Systems, Inc. | Method and apparatus for applying vascular grafts |
WO1994023786A1 (en) | 1993-04-13 | 1994-10-27 | Boston Scientific Corporation | Prosthesis delivery system |
US5425765A (en) | 1993-06-25 | 1995-06-20 | Tiefenbrun; Jonathan | Surgical bypass method |
US5445600A (en) | 1994-04-29 | 1995-08-29 | Abdulla; Ra-Id | Flow control systemic to pulmonary arterial shunt |
US5653743A (en) | 1994-09-09 | 1997-08-05 | Martin; Eric C. | Hypogastric artery bifurcation graft and method of implantation |
WO1996032078A1 (en) | 1995-04-14 | 1996-10-17 | Schneider (Usa) Inc. | Rolling membrane stent delivery device |
US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
US6150164A (en) | 1996-09-30 | 2000-11-21 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
EP1018982B1 (en) | 1996-12-03 | 2005-03-09 | Osteobiologics, Inc. | Biodegradable polymeric film |
US6086526A (en) | 1997-04-11 | 2000-07-11 | Medtronic, Inc. | Cardiac assistance system |
US5984955A (en) | 1997-09-11 | 1999-11-16 | Wisselink; Willem | System and method for endoluminal grafting of bifurcated or branched vessels |
AUPP083597A0 (en) | 1997-12-10 | 1998-01-08 | William A Cook Australia Pty Ltd | Endoluminal aortic stents |
US6395018B1 (en) | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US6344052B1 (en) | 1999-09-27 | 2002-02-05 | World Medical Manufacturing Corporation | Tubular graft with monofilament fibers |
US20020198585A1 (en) | 1999-10-05 | 2002-12-26 | Willem Wisselink | System and method for edoluminal grafting of bifurcated or branched vessels |
US6908477B2 (en) | 2000-10-13 | 2005-06-21 | Rex Medical, L.P. | Methods of implanting covered stents with side branch |
US6814754B2 (en) | 2000-10-30 | 2004-11-09 | Secant Medical, Llc | Woven tubular graft with regions of varying flexibility |
US20040106972A1 (en) | 2000-11-20 | 2004-06-03 | Deaton David H. | Fenestrated endovascular graft |
AU2003224769B2 (en) | 2002-03-25 | 2007-10-18 | Cook Incorporated | Branched vessel prothesis |
US20040034406A1 (en) | 2002-08-19 | 2004-02-19 | Thramann Jeffrey J. | Vascular stent grafts |
US7550004B2 (en) | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
US20040059406A1 (en) | 2002-09-20 | 2004-03-25 | Cully Edward H. | Medical device amenable to fenestration |
US7438721B2 (en) | 2003-04-25 | 2008-10-21 | Medtronic Vascular, Inc. | Universal modular stent graft assembly to accommodate flow to collateral branches |
US7651519B2 (en) | 2003-09-16 | 2010-01-26 | Cook Incorporated | Prosthesis deployment system |
EP1673039B1 (en) | 2003-10-10 | 2008-12-03 | William A. Cook Australia Pty. Ltd. | Stent graft fenestration |
US7413573B2 (en) | 2003-10-10 | 2008-08-19 | William A. Cook Australia Pty. Ltd. | Fenestrated stent grafts |
US8808351B2 (en) | 2003-10-10 | 2014-08-19 | Cook Medical Technologies Llc | Stretchable prosthesis fenestration |
US8012193B2 (en) | 2003-10-14 | 2011-09-06 | William A. Cook Australia Pty, Ltd | Introducer for an iliac side branch device |
WO2005037142A2 (en) | 2003-10-15 | 2005-04-28 | Cook Incorporated | Prosthesis deployment system retention device |
US9078780B2 (en) | 2003-11-08 | 2015-07-14 | Cook Medical Technologies Llc | Balloon flareable branch vessel prosthesis and method |
US8048140B2 (en) * | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US7758633B2 (en) | 2004-04-12 | 2010-07-20 | Boston Scientific Scimed, Inc. | Varied diameter vascular graft |
EP1776066B1 (en) * | 2004-07-02 | 2012-02-08 | Cook Medical Technologies LLC | Stent having arcuate struts |
US20060247760A1 (en) | 2005-04-29 | 2006-11-02 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent branch arteries |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
US7678141B2 (en) | 2006-04-18 | 2010-03-16 | Medtronic Vascular, Inc. | Stent graft having a flexible, articulable, and axially compressible branch graft |
US20070244547A1 (en) | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc., A Delaware Corporation | Device and Method for Controlling the Positioning of a Stent Graft Fenestration |
US7959668B2 (en) * | 2007-01-16 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20090030502A1 (en) | 2007-07-26 | 2009-01-29 | Jichao Sun | Socket For Fenestrated Tubular Prosthesis |
GB0721459D0 (en) | 2007-11-01 | 2007-12-12 | Vascutek Ltd | Apparatus and method |
US20090164001A1 (en) | 2007-12-21 | 2009-06-25 | Biggs David P | Socket For Fenestrated Tubular Prosthesis |
GB0803302D0 (en) | 2008-02-22 | 2008-04-02 | Barts & London Nhs Trust | Blood vessel prosthesis and delivery apparatus |
US8100960B2 (en) | 2008-03-20 | 2012-01-24 | Medtronic Vascular, Inc. | Bloused stent-graft and fenestration method |
US20090259290A1 (en) | 2008-04-14 | 2009-10-15 | Medtronic Vascular, Inc. | Fenestration Segment Stent-Graft and Fenestration Method |
US8128686B2 (en) | 2008-04-18 | 2012-03-06 | Cook Medical Technologies Llc | Branched vessel prosthesis |
US8206430B2 (en) | 2008-04-21 | 2012-06-26 | Medtronic Vascular, Inc. | Endolumenal sealant delivery apparatus and methods |
EP2331011B1 (en) | 2008-08-29 | 2015-01-14 | Cook Medical Technologies LLC | Prosthesis with moveable fenestration |
US8540764B2 (en) | 2009-04-17 | 2013-09-24 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US8506622B2 (en) * | 2009-04-17 | 2013-08-13 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
EP2429452B1 (en) | 2009-04-28 | 2020-01-15 | Endologix, Inc. | Endoluminal prosthesis system |
US20110270379A1 (en) | 2010-04-29 | 2011-11-03 | Medtronic Vascular, Inc. | Mobile External Coupling for Branch Vessel Connection |
US8523932B2 (en) | 2010-05-24 | 2013-09-03 | Cook Medical Technologies Llc | Variable diameter trigger wire |
AU2010210022B1 (en) * | 2010-08-05 | 2011-09-08 | Cook Incorporated | Stent graft having a marker and a reinforcing and marker ring |
US8702786B2 (en) | 2010-08-21 | 2014-04-22 | Cook Medical Technologies Llc | Prosthesis having pivoting fenestration |
US8771336B2 (en) | 2010-08-21 | 2014-07-08 | Cook Medical Technologies Llc | Endoluminal prosthesis comprising a valve replacement and at least one fenestration |
CA2748206C (en) * | 2010-08-21 | 2015-06-23 | Blayne A. Roeder | Prosthesis having pivoting fenestration |
US9839542B2 (en) * | 2011-04-19 | 2017-12-12 | Medtronic Ardian Luxembourg S.A.R.L. | Mobile external coupling for branch vessel connection |
-
2013
- 2013-03-14 US US13/826,289 patent/US10265202B2/en active Active
-
2014
- 2014-03-04 EP EP14275040.5A patent/EP2777607B8/en active Active
-
2019
- 2019-03-05 US US16/292,456 patent/US20190192320A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190247051A1 (en) * | 2018-02-15 | 2019-08-15 | Fareed Siddiqui | Active textile endograft |
Also Published As
Publication number | Publication date |
---|---|
US10265202B2 (en) | 2019-04-23 |
EP2777607B1 (en) | 2016-04-27 |
EP2777607A1 (en) | 2014-09-17 |
EP2777607B8 (en) | 2016-07-06 |
US20140277335A1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190192320A1 (en) | Prosthesis having an everting pivoting fenestration | |
US10159560B2 (en) | Prosthesis having pivoting fenestration | |
US20230293284A1 (en) | Endoluminal prosthesis having multiple branches or fenestrations and methods of deployment | |
US10188503B2 (en) | Prosthesis having pivoting fenestration | |
US9907680B2 (en) | Sliding fenestration | |
US8702786B2 (en) | Prosthesis having pivoting fenestration | |
US9351822B2 (en) | Prosthesis having pivoting fenestration | |
US8002816B2 (en) | Prosthesis for implantation in aorta and method of using same | |
EP1696828B1 (en) | Interconnected leg extensions for an endoluminal prostehsis | |
US7674284B2 (en) | Endoluminal graft | |
US9265599B2 (en) | Retention system for an endoluminal device | |
EP2749250A1 (en) | Endoluminal posthesis | |
EP3449871A2 (en) | Endoluminal prosthesis with an aortic sinus stent assembly | |
WO2013130390A1 (en) | Prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |